Medical Research Council
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- -
- Established
- 1913-01-01
- Employees
- -
- Market Cap
- -
Methyl-Donors and EpiGenetics in The Gambia
Completed
- Conditions
- Aberrant DNA Methylation
- Interventions
- Other: season, dietary intake
- First Posted Date
- 2013-03-14
- Last Posted Date
- 2016-03-22
- Lead Sponsor
- Medical Research Council
- Target Recruit Count
- 166
- Registration Number
- NCT01811641
Evaluation of a Parenting and Stress Management Programmme
Not Applicable
Terminated
- Conditions
- ParentingParent Mental HealthChild Behaviour Problems
- Interventions
- Behavioral: Combination of Triple P Discussion Groups and Stress Control
- First Posted Date
- 2013-01-29
- Last Posted Date
- 2014-07-18
- Lead Sponsor
- Medical Research Council
- Target Recruit Count
- 14
- Registration Number
- NCT01777724
- Locations
- 🇬🇧
Medical Research Council Social and Public Health Sciences Unit, Glasgow, United Kingdom
ICON8: Weekly Chemotherapy in Ovarian Cancer
- First Posted Date
- 2012-07-31
- Last Posted Date
- 2012-07-31
- Lead Sponsor
- Medical Research Council
- Target Recruit Count
- 1485
- Registration Number
- NCT01654146
- Locations
- 🇬🇧
Medical Research Council Clinical Trials Unit, London, United Kingdom
Protease Inhibitor Monotherapy Versus Ongoing Triple-therapy in the Long Term Management of HIV Infection (PIVOT)
Phase 4
- Conditions
- HIV InfectionAcquired Immunodeficiency Syndrome
- Interventions
- Drug: Standard-of-care Antiretroviral therapy
- First Posted Date
- 2010-10-29
- Last Posted Date
- 2012-10-10
- Lead Sponsor
- Medical Research Council
- Target Recruit Count
- 587
- Registration Number
- NCT01230580
Evaluation of the Efficacy of Hydroxychloroquine in Decreasing Immune Activation in Asymptomatic HIV-infected Patients
- First Posted Date
- 2010-02-11
- Last Posted Date
- 2010-07-30
- Lead Sponsor
- Medical Research Council
- Target Recruit Count
- 83
- Registration Number
- NCT01067417
Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1/2-uninfected Mothers
Phase 1
Completed
- Conditions
- HIV-1HIV Infections
- Interventions
- Biological: MVA.HIVA
- First Posted Date
- 2009-09-23
- Last Posted Date
- 2012-02-03
- Lead Sponsor
- Medical Research Council
- Target Recruit Count
- 48
- Registration Number
- NCT00982579
- Locations
- 🇬🇲
Medical Research Council Laboratories, The Gambia, Banjul, Fajara, Gambia
Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1-infected Mothers
Phase 1
- Conditions
- HIV-1HIV Infections
- Interventions
- Biological: MVA.HIVA
- First Posted Date
- 2009-09-22
- Last Posted Date
- 2011-06-16
- Lead Sponsor
- Medical Research Council
- Target Recruit Count
- 72
- Registration Number
- NCT00981695
- Locations
- 🇰🇪
Kenyatta National Hospital, Nairobi, Kenya
Study of Tumor Tissue Testing in Selecting Treatment for Patients With Metastatic or Locally Advanced Colorectal Cancer
Phase 2
Completed
- Conditions
- Colorectal Cancer
- First Posted Date
- 2009-09-14
- Last Posted Date
- 2013-12-19
- Lead Sponsor
- Medical Research Council
- Target Recruit Count
- 3240
- Registration Number
- NCT00975897
- Locations
- 🇬🇧
Belfast City Hospital Trust Incorporating Belvoir Park Hospital, Belfast, Northern Ireland, United Kingdom
🇬🇧Leeds Cancer Centre at St. James's University Hospital, Leeds, England, United Kingdom
🇬🇧Velindre Cancer Center at Velindre Hospital, Cardiff, Wales, United Kingdom
Radiation Therapy or Standard Therapy in Treating Women With Stage II Breast Cancer Who Have Undergone Mastectomy
Phase 3
- Conditions
- Breast Cancer
- Interventions
- Radiation: radiation therapyProcedure: standard follow-up care
- First Posted Date
- 2009-08-27
- Last Posted Date
- 2013-08-12
- Lead Sponsor
- Medical Research Council
- Target Recruit Count
- 3500
- Registration Number
- NCT00966888
- Locations
- 🇬🇧
Edinburgh Cancer Centre at Western General Hospital, Edinburgh, Scotland, United Kingdom
🇬🇧Royal Infirmary - Castle, Glasgow, Scotland, United Kingdom
DNA Analysis of Blood and/or Tissue Samples From Patients With Primary Kidney Cancer Receiving Sorafenib on Clinical Trial MRC-RE05-SORCE
Completed
- Conditions
- Kidney Cancer
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2013-08-12
- Lead Sponsor
- Medical Research Council
- Registration Number
- NCT00900536
- Locations
- 🇬🇧
Addenbrooke's Hospital, Cambridge, England, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath